High Throughput Production of mRNA скачать в хорошем качестве

High Throughput Production of mRNA

For more information on other ways AWS can help your healthcare and life sciences organization, visit us at: https://amzn.to/2NP30RW or contact the team at: [email protected]. We hope that you enjoyed hearing from industry leaders about how they are working to expedite therapy development, incorporate digital therapeutics at scale, and improve patient outcomes. Moderna Therapeutics (NASDAQ: MRNA) is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immunooncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.